Alector, Inc. (ALEC) Stock Grade

About Alector, Inc.'s fundamentals

Alector, Inc. is a biotechnology company with a market capitalization of $213.2 million that experienced severe financial deterioration in its latest reporting period, with revenue declining 79.1% year-over-year. The company reported a substantial net loss, resulting in a net margin of -679.2%, indicating it is spending significantly more than it generates in revenue. As a pre-profitability biotech firm, Alector does not pay a dividend and traditional profitability metrics like P/E ratio and return on equity are not applicable.